ArticleCommunications biology2025
Osr1 orchestrates posterior second heart field cell migration for outflow tract formation.
Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Congenital heart defects, particularly those affecting the outflow tract (OFT), represent a significant cause of neonatal morbidity and mortality. The genetic and cellular mechanisms underlying OFT abnormalities, especially the migration of second heart field (SHF) cells, remain poorly understood. In this study, we identify two distinct migratory pathways for Osr1-expressing posterior SHF cells directed toward the OFT and inflow tract (IFT). We show that Osr1 regulates two key ligand-receptor signaling axes, Hedgehog-Ptch1 and Cxcl12-Cxcr7, both of which are essential for the directed migration of Osr1⁺ cells toward the OFT. We establish that Smo and Ackr3 (encoding CXCR7) are direct transcriptional targets of Osr1. Functional studies demonstrate that Osr1-Hh signaling governs SHF cell migration and OFT development, while Osr1-Cxcl12 signaling likely acts in synergy to support this process. These findings underscore the pivotal role of Osr1+ pSHF cells in directing heart pole development and reveal crucial ligand-receptor interactions involved in cell migration, potentially guiding future therapeutic targets for congenital heart defects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.